Quantinuum (NASDAQ:QNT) Stock Keeps Buy Rating at Rosenblatt Securities

Quantinuum (NASDAQ:QNT – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Rosenblatt Securities in a research note issued on Thursday, Benzinga reports. They presently have a $155.00 price target on the stock. Rosenblatt Securities‘s price target suggests a potential upside of 324.66% from the company’s current price.

Other research analysts have also recently issued reports about the company. Sanford C. Bernstein reissued a “hold” rating on shares of Quantinuum in a report on Wednesday, August 12th. JPMorgan Chase & Co. began coverage on Quantinuum in a report on Monday, June 29th. They issued an “overweight” rating and a $97.00 price target on the stock. Mizuho began coverage on Quantinuum in a report on Monday, June 29th. They issued an “outperform” rating and a $90.00 price target on the stock. UBS Group began coverage on Quantinuum in a report on Monday, June 29th. They issued a “buy” rating and a $93.00 price target on the stock. Finally, Wall Street Zen cut Quantinuum from a “hold” rating to a “sell” rating in a report on Saturday, July 4th. Thirteen investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $94.23.

Get Our Latest Analysis on Quantinuum

Quantinuum Stock Performance

NASDAQ QNT traded up $0.60 during trading hours on Thursday, hitting $36.50. The company’s stock had a trading volume of 1,156,763 shares, compared to its average volume of 2,315,933. Quantinuum has a 12 month low of $33.02 and a 12 month high of $86.79. The stock has a 50 day moving average price of $47.51. The company has a market capitalization of $9.61 billion and a P/E ratio of -130.36.

Quantinuum (NASDAQ:QNT – Get Free Report) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.02). The business had revenue of $8.00 million during the quarter. On average, equities analysts predict that Quantinuum will post -4.76 EPS for the current year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. CoreCap Advisors LLC purchased a new position in Quantinuum in the 3rd quarter worth approximately $32,000. IFP Advisors Inc lifted its holdings in Quantinuum by 1,150.0% in the 3rd quarter. IFP Advisors Inc now owns 1,250 shares of the company’s stock worth $60,000 after purchasing an additional 1,150 shares in the last quarter. Steel Grove Capital Advisors LLC raised its holdings in shares of Quantinuum by 25.6% during the 3rd quarter. Steel Grove Capital Advisors LLC now owns 5,992 shares of the company’s stock worth $288,000 after acquiring an additional 1,222 shares in the last quarter. SBI Securities Co. Ltd. raised its holdings in shares of Quantinuum by 52.8% during the 3rd quarter. SBI Securities Co. Ltd. now owns 6,778 shares of the company’s stock worth $326,000 after acquiring an additional 2,343 shares in the last quarter. Finally, Canton Hathaway LLC raised its holdings in shares of Quantinuum by 21.5% during the 3rd quarter. Canton Hathaway LLC now owns 22,748 shares of the company’s stock worth $1,093,000 after acquiring an additional 4,023 shares in the last quarter.

About Quantinuum

(Get Free Report)

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.

Featured Stories

Analyst Recommendations for Quantinuum (NASDAQ:QNT)

Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.